Skip to main content
Log in

Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma

  • Special Annual Issue
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Objectives

This study analyzed the intratumoral activity of interferon alpha (IFN-α) in the treatment of cystic craniopharyngiomas.

Patients and methods

From January 2000 to January 2004, nine patients presenting with cystic craniopharyngiomas were treated with intratumoral injection of IFN-α at the Pediatric Oncology Institute of the Federal University of São Paulo–Escola Paulista de Medicina. Age ranged from 1 year and 10 months to 18 years (mean 10 years). All intratumoral catheters were inserted by a subfrontal approach. Doses varied from 36 to 108 MU.

Results

There was complete disappearance of the lesion in seven cases. In two cases, partial reduction of tumor size was observed at follow-up. Follow-up varied from 1 year to 3 years and 6 months (mean 1 year 8 months).

Conclusions

IFN-α proved to be an effective drug in the control of cystic craniopharyngiomas. Additional studies should be carried out to determine the optimal dose of IFN-α in the treatment of cystic craniopharyngioma. In addition, other drugs possessing high efficacy and low neurotoxicity should be analyzed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Carmel PW (1990) Tumours of disordered embryogenesis. In: Youmans JR (ed) Neurological surgery, 3rd edn. WB Saunders, Philadelphia, pp 3223–3249

    Google Scholar 

  2. Cavalheiro S, Sparapani FVC, Franco JOB, Da Silva MC, Braga FM (1996) Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. J Neurosurg 84:124–126

    Google Scholar 

  3. Chamberlain MC (2002) A phase II trial of intra-cerebrospinal fluid alpha interferon in the treatment of neoplastic meningitis. Cancer 94:2675–2680

    Article  CAS  PubMed  Google Scholar 

  4. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8:237–249

    Article  CAS  PubMed  Google Scholar 

  5. Choux M, Lena G, Genitori L (1991) Le craniopharyngiome de l’enfant. Neurochirurgie 37:113–128

    Google Scholar 

  6. Gutterman JU (1994) Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci U S A 99:1198–1205

    Google Scholar 

  7. Jakacki RI, Cohen BH, Jamison C, Mathews VP, Arenson E, Longee DC, Hilden J, Cornelius AL, Needle M, Heilman D, Boaz JC, Luerssen TG (2000) Phase II evaluation of interferon-α-2a for progressive or recurrent craniopharyngiomas. J Neurosurg 92:255–260

    CAS  PubMed  Google Scholar 

  8. Laws ER Jr (1994) Transsphenoidal removal of craniopharyngioma. Pediatr Neurosurg 21(Suppl 1):57–63

    PubMed  Google Scholar 

  9. Muhr C, Gudjonsson O, Lilja A, Hartman M, Zhang Z, Langströn B (2001) Meningioma treated with interferon-α, evaluated with [11C]-l-methionine positron emission tomography. Clin Cancer Res 7:2269–2276

    CAS  PubMed  Google Scholar 

  10. Russel DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system, 5th edn. Edward Arnold, London, p 695

    Google Scholar 

  11. Savas A, Erdem A, Tun K, Yücel K (2000) Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 46:213–217

    Google Scholar 

  12. Selleri C, Sato T, Del Vecchio L, Luciano L, Barret Aj, Rotoli B, Young NS, Maciejewski JP (1997) Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood 89:957–964

    CAS  PubMed  Google Scholar 

  13. Symon L (1994) An approach to radical excision of craniopharyngioma in children. Pediatr Neurosurg 21(Suppl):64–68

    PubMed  Google Scholar 

  14. Tagliaferri P, Caraglia M, Budilon A, Marra M, Vitali G, Viscomi C, Masciari S, Tassone P, Abbruzzese A, Venuta S (2005) New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer. Cancer Immunol Immunother 54:1–10

    Article  CAS  PubMed  Google Scholar 

  15. Takahashi H, Nakazawa S, Shimura T (1985) Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg 62:120–127

    Google Scholar 

  16. Takeuchi K (1976) Effect of bleomycin on brain tumors. In: Carter SK, Ichikawa T, Mathe G et al (eds) Fundamental and clinical studies of bleomycin. Gann monograph on cancer research, No. 19. Japan Scientific Societies Press, Tokyo, pp 117–132

    Google Scholar 

  17. Wisoff JH (1994) Surgical management of recurrent craniopharyngiomas. Pediatr Neurosurg 21(Suppl 1):108–113

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Cavalheiro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cavalheiro, S., Dastoli, P.A., Silva, N.S. et al. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma. Childs Nerv Syst 21, 719–724 (2005). https://doi.org/10.1007/s00381-005-1226-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-005-1226-1

Keywords

Navigation